To accommodate patients remotely during the COVID-19 pandemic, practices may have expanded personnel access to protected health information and relied on devices that might be vulnerable to cyber attacks.
Researchers analyzed data from patients with chronic hepatitis B to identify predictors of relapse in those who discontinued NAs and determined if existing rules for stopping NA therapy can be improved.
Researchers analyzed data from patients with chronic hepatitis B to identify predictors of relapse in those who discontinued NAs and determined if existing rules for stopping NA therapy can be improved.
In December 2020, researchers conducted a survey of 1027 adults to determine percentage of those receiving, or intending to receive, influenza vaccination.
The objective of this quasi-experimental observational study was to measure the effect of states’ hospital worker influenza vaccination laws on pneumonia and influenza mortality.
The test correctly identified 96% of positive samples from individuals known to have symptoms and 100% of positive samples from individuals without symptoms.
Study authors assessed the economic trade-offs of expanding and accelerating testing for SARS-CoV-2 across the United States in different transmission scenarios.
The airline industry requested the White House for standardized COVID-19 credentials for passengers, as they believe that 1 set of rules for such documents will help revive travel.
The US Food and Drug Administration is warning against reliance on pulse oximeters for diagnosis and treatment decisions for COVID-19 and other conditions.
Study authors conducted a retrospective study to determine the anti-SARS-CoV-2 IgG antibody levels in convalescent plasma used to treat hospitalized patients with COVID-19.
Researchers from the New York State Department of Health found that current COVID-19 convalescent plasma guidelines may be allowing for sera with low neutralizing capacity to be administered.
The randomized, placebo-controlled, observer-blind study is evaluating the safety, tolerability, and immunogenicity of BNT162b2 in approximately 4000 healthy pregnant women aged 18 years and older who are 24 to 34 weeks’ gestation.
